共 106 条
[1]
Rosewicz S(1997)Pancreatic carcinoma Lancet 349 485-489
[2]
Wiedenmann B(2002)Cancer statistics, 2002 CA Cancer J Clin 52 23-47
[3]
Jemal A(2002)Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials Semin Oncol 29 9-16
[4]
Thomas A(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403-2413
[5]
Murray T(2007)Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 1960-1966
[6]
Thun M(2007)Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group J Clin Oncol 25 2212-2217
[7]
Heinemann V(2007)Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries Jpn J Clin Oncol 37 884-891
[8]
Burris HA(1997)Gemcitabine: safety profile and efficacy in non-small cell lung cancer unaffected by age Aging (Milano) 9 297-303
[9]
Moore MJ(2006)Current treatment strategies for pancreatic cancer in the elderly Drugs Aging 23 403-410
[10]
Andersen J(2008)Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer Pancreas 36 e16-e21